Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about XLRN
Recent news which mentions XLRN
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
Tickers
ABBV
ADXN
AGTC
AKYA
Tags
ABBV
LLY
EDIT
From
Benzinga
Notable Acceleron Pharma Insider Trades $1.08 Million In Company Stock
September 28, 2021
Tickers
XLRN
Tags
BZI/IT
Market News
Insider sells
From
Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
Tickers
AFIB
ALT
AMZN
APYX
Tags
AFIB
CRDL
PASG
From
Benzinga
These sectors are looking so cheap that ESG considerations will have to be put on standby, strategist says
September 28, 2021
Tickers
FB
MRK
XLRN
Tags
BX:TMUBMUSD10Y
XLRN
NQ00
From
MarketWatch
Merck Reportedly Lead Bidder In $11B Acceleron Buyout: WSJ
September 28, 2021
Tickers
BMY
MRK
XLRN
Tags
M&A
Market News
MRK
From
Benzinga
A Peek Into The Markets: US Stock Futures Down Ahead Of Economic Data, Fed Speakers
September 28, 2021
Tickers
EDR
F
FDS
MRK
Tags
News
Futures
Pre/Market Outlook
From
Benzinga
5 Stocks To Watch For September 28, 2021
September 28, 2021
Tickers
FDS
MRK
MU
UNFI
Tags
MRK
Market News
Stocks to Watch
From
Benzinga
Merck nears deal for rare-disease-drug maker Acceleron
September 28, 2021
Tickers
BMY
MRK
XLRN
Tags
XLRN
BMY
MRK
From
MarketWatch
Why Acceleron Pharma Stock Is Trading Higher Today
September 27, 2021
Tickers
XLRN
Tags
why it's moving
News
XLRN
From
Benzinga
CFO & Treasurer Of Acceleron Pharma Trades $5.01 Million In Company Stock
September 27, 2021
Tickers
XLRN
Tags
XLRN
News
Kevin F Mclaughlin
From
Benzinga
10 Biggest Price Target Changes For Monday
September 27, 2021
Tickers
AMZN
AZN
BBBY
COST
Tags
XLRN
NKE
Price Target
From
Benzinga
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
Tickers
AMGN
BMY
GILD
MRK
Tags
RHHBY
BMY
MRK
From
Benzinga
Why Acceleron Pharma Stock Jumped This Week
September 25, 2021
Tickers
BMY
JNJ
XLRN
Tags
JNJ
Market News
XLRN
From
Motley Fool
SVP And General Counsel Sec. Of Acceleron Pharma Trades $1.21 Million In Company Stock
September 23, 2021
Tickers
XLRN
Tags
Insider Trades
Insider sells
Adam M Veness
From
Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Tickers
ABCL
ABSI
AFIB
ALZN
Tags
CSII
INCY
NXTC
From
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
Tickers
ABEO
ABSI
AFIB
AMAM
Tags
IVA
ONTX
CNTA
From
Benzinga
30 stocks that shined in the pandemic are still poised for huge growth through 2024
August 31, 2021
Tickers
CHPT
CRWD
CVNA
DKNG
Tags
TXG
PLUG
DKNG
From
MarketWatch
Acceleron Pharma inc (XLRN) Q2 2021 Earnings Call Transcript
August 05, 2021
Tickers
XLRN
Tags
Market News
XLRN
From
Motley Fool
Acceleron Pharma: Q2 Earnings Insights
August 05, 2021
Tickers
XLRN
Tags
Benzinga
Earnings
Market News
From
Benzinga
Earnings Scheduled For August 5, 2021
August 05, 2021
Tickers
TCX
TDC
TDS
TECH
Tags
ZEUS
VRAY
News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.